Page breadcrumb nav

VAERS Report 2156824

Case Report Section

Vaer Report Details

Age: NA

Gender: Female

State: Outside US

Patient Died?
Vaccine information


Type: Coronavirus 2019 vaccine

Manufacturer: PFIZER

Lot: unknown

Date report was received
Date form completed
Date Vaccinated
Date of Onset
Number of days (onset date – vaccination date)
Adverse Event Description

pain; restricted range of movement; numbness; tingling in little finger and ring finger; off label use; interchange of vaccine product; shoulder pain; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority. regulatory number: gb-mhra-webcovid-202202181054239110-zhebo. other case identifier(s): gb-mhra-adr 26619662. a female patient received bnt162b2 (comirnaty), administration date 27nov2021 (batch/lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "suspected covid-19", start date: 30dec2020 (unspecified if ongoing), notes: unsure when symptoms stopped; "steroid therapy" (unspecified if ongoing), notes: taking regular steroid treatment (e.g. orally or rectally); "asthma" (unspecified if ongoing). concomitant medication(s) included: qvar easi-breathe taken for asthma. vaccination history included: covid-19 vaccine astrazeneca, administration date: 15mar2021, for covid-19 immunisation; covid-19 vaccine astrazeneca, administration date: 31may2021, for covid-19 immunisation. the following information was reported: off label use (medically significant) with onset 27nov2021, outcome "unknown", described as "off label use"; interchange of vaccine products (medically significant) with onset 27nov2021, outcome "unknown", described as "interchange of vaccine product"; arthralgia (medically significant) with onset 27nov2021, outcome "not recovered", described as "shoulder pain"; pain (medically significant), outcome "unknown", described as "pain"; movement disorder (medically significant), outcome "unknown", described as "restricted range of movement"; hypoaesthesia (medically significant), outcome "unknown", described as "numbness"; paraesthesia (medically significant), outcome "unknown", described as "tingling in little finger and ring finger". the events "shoulder pain", "restricted range of movement", "numbness" and "tingling in little finger and ring finger" were evaluated at the physician office visit. the patient underwent the following laboratory tests and procedures: sars-cov-2 test: inconclusive test, notes: inconclusive test. clinical course: within hours of booster, the patient experienced severe pain in shoulder above vaccination site. three months later now and still have pain and restricted range of movement as well as numbness and tingling in little finger and ring finger on same side. the patient had a phone appointment with gp who was quite off hand and dismissive. the patient is not enrolled in clinical trial. the patient consulted an osteopath to try and gain more range of movement in shoulder as it is affecting daily life. "quarter inhaler daily" was reported. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Lab Data
test name: covid-19 virus test; result unstructured data: test result:inconclusive test; comments: inconclusive test
List of symptoms
paraesthesia arthralgia pain movement disorder hypoaesthesia interchange of vaccine products sars-cov-2 test off label use
Patient Died?
Date Died
Birth defect
Vaccine Administered By:
Vaccine Purchased By:
Patient visit ER?
Patient Hospitalized?
Stay in hospital
Days in hospital
Permanent disability?
Current Illness